HealthCare Global Enterprises Limited has submitted its Monitoring Agency Report for the quarter ended June 30, 2026. The report, issued by CARE Ratings Limited, details the utilization of proceeds from the Company’s Rights Issue. All specified objects of the issue have been completed as per the offer document, with no material deviations noted.
Monitoring Agency Report Submitted
HealthCare Global Enterprises Limited has filed the Monitoring Agency Report for the quarter ended June 30, 2026, in relation to its recent Rights Issue. The report was submitted to the National Stock Exchange of India Limited and BSE Limited, as per SEBI regulations.
Utilization of Rights Issue Proceeds
The report, prepared by CARE Ratings Limited, confirms that the utilization of the Rights Issue proceeds is in line with the disclosures made in the Offer Document. Key objectives monitored include the pre-payment and/or repayment of outstanding borrowings (₹170.00 crore) and the part-payment for the acquisition of an additional stake in Vizag Hospital and Cancer Research Center Private Limited (₹154.04 crore). Both these objectives have been fully utilized as of Q1FY27.
Additionally, General Corporate Purposes saw an allocation of ₹95.83 crore, which includes unutilized amounts from the issue-related expenses. The total utilized amount for these purposes was within the prescribed limits of 25% of the Gross Proceeds.
Status of Objects and Deviations
The report indicates that all objects of the issue have been successfully completed. There were no deviations observed from the stated objectives or the terms outlined in the Offer Document. The implementation of all objects was completed within the initially projected timelines, with no delays reported.
Issue-related expenses amounted to ₹4.81 crore, slightly less than the estimated allocation of ₹5.07 crore. The unutilized balance of ₹0.26 crore was channeled towards General Corporate Purposes.
Source: BSE
